About Dr. Robinson
Dr. Jason D. Robinson is an Associate Professor in the Department of Behavioral Science at the University of Texas MD Anderson Cancer Center and a member of its Tobacco Research and Treatment Program. As a clinical psychologist, he began his research career as a human psychophysiologist, centered on identifying the neurobehavioral adaptations that result from smoking, identifying the individual, genetic, and developmental differences that influence these neurobehavioral adaptations, and modifying these neurobehavioral adaptations using novel pharmacological and non-pharmacological approaches. He has also pursued research in the use of genetics to identify nicotine dependence phenotypes, the stress hormone response to smoking, the treatment of nicotine dependence among at-risk populations, and new drug development for the treatment of nicotine dependence. More recently, Dr. Robinson has engaged in research evaluating the potential risks and benefits of alternative nicotine products, particularly electronic cigarettes, among smokers who switch to them.
Associate Professor, Department of Behavioral Science, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Director, Behavioral Research & Treatment Center, The University of Texas MD Anderson Cancer Center, Houston, TX
|2002||Purdue University, West Lafayette, IN, USA, PHD, Clinical Psychology|
|1997||Purdue University, West Lafayette, IN, USA, MS, Clinical Psychology|
|1993||Purdue University, West Lafayette, IN, USA, BA, Psychology|
- Cinciripini PM, Karam-Hage M, Kypriotakis G, Robinson JD, Rabius V, Beneventi D, Minnix JA, Blalock JA. Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open 2(9):e1912251, 2019. e-Pub 2019. PMID: 31560387.
- Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychol Addict Behav 33(2):105-116, 2019. e-Pub 2019. PMID: 30614717.
- Robinson JD, Kypriotakis G, Karam-Hage M, Green CE, Hatsukami DK, Cinciripini PM, Donny EC. Cigarette nicotine content as a moderator of the relationship between negative affect and smoking. Nicotine Tob Res 19(9):1080-1086, 2017. e-Pub 2017. PMID: 28371900.
- Farris SG, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, Karam-Hage M, Blalock JA. Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment. Addict Behav 61:32-39, 2016. e-Pub 2016. PMID: 27235990.
- Deweese MM, Robinson JD, Cinciripini PM, Versace F. Conditioned cortical reactivity to cues predicting cigarette-related or pleasant images. Int J Psychophysiol 101:59–68, 2016. e-Pub 2016. PMID: 26826400.
- Cui Y, Tang R, Lam CY, Cinciripini PM, Robinson JD. The influence of personality traits on smokers' affect, withdrawal and cessation intervention outcome. Addict Behav 54:7-11, 2016. e-Pub 2015. PMID: 26656672.
- Robinson JD, Versace F, Engelmann JM, Cui Y, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM. Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy. J Psychopharmacol 30(7):627-640, 2016. e-Pub 2016. PMID: 27097731.
- Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL. Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts. Behav Genet 46:151-169, 2016. e-Pub 2015. PMID: 26392368.
- Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK. Randomized trial of reduced-nicotine standards for cigarettes. N Engl J Med 373(14):1340-1349, 2015. PMID: 26422724.
- Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM. Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses. Psychol Addict Behav 29(2):300-311, 2015. PMID: 25621416.
- Robinson JD, Versace F, Engelmann JM, Cui Y, Slapin A, Oum R, Cinciripini PM. The motivational salience of cigarette-related stimuli among former, never, and current smokers. Exp Clin Psychopharmacol 23(1):37-48, 2015. e-Pub 2014. PMID: 25436840.
- Robinson JD, Engelmann JM, Cui Y, Versace F, Waters AJ, Gilbert DG, Gritz ER, Cinciripini PM. The effects of nicotine dose expectancy and motivationally relevant distracters on vigilance. Psychol Addict Behav 28(3):752-760, 2014. e-Pub 2014. PMID: 24841184.
- Versace F, Engelmann JM, Robinson JD, Jackson EF, Green CE, Lam CY, Minnix JA, Karam-Hage MA, Brown VL, Wetter DW, Cinciripini PM. Pre-quit fMRI responses to pleasant cues and cigarette-related cues predict smoking cessation outcome. Nicotine Tob Res 16(6):697-708, 2014. e-Pub 2013. PMID: 24376278.
- Waters AJ, H Szeto E, Wetter DW, Cinciripini PM, Robinson JD, Li Y. Cognition and craving during smoking cessation: An ecological momentary assessment study. Nicotine Tob Res 16(suppl. 2):S111-S118, 2014. PMID: 23901053.
- Karam-Hage M, Robinson JD, Lodhi A, Brower KJ. Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: A naturalistic, open-label study. Curr Clin Pharmacol 9(2):123-129, 2014. PMID: 24218993.
- Robinson JD, Kypriotakis G, al'Absi M, Denlinger-Apte RL, Drobes DJ, Leischow S, McClernon FJ, Pacek LR, Severson H, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK. Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior. Nicotine Tob Res. e-Pub 2019. PMID: 31701153.
- Robinson JD, Drobes DJ, Brandon TH, Wetter DW, Cinciripini PM. Evaluating point of sale tobacco marketing using behavioral laboratory methods. Tob Regul Sci 2(4):414-425, 2016.
|Title:||Identifying topiramate's therapeutic mechanisms through motivational salience|
|Title:||Using Deep Sequencing Technology to Study Genes & Behavioral Phenotypes Related to Smoking Cessation, Negative Affect & Nicotine Withdrawal|
|Funding Source:||Cancer Prevention & Research Institute of Texas (CPRIT)|
|Title:||Intrinsic Reward Sensitivity & Smoking Cessation with Varenicline or Patch NRT|
|Funding Source:||Cancer Prevention & Research Institute of Texas (CPRIT)|
|Title:||Smartphone delivered attentional bias modification training for smokers|
|Title:||Neurobiological substrates of emotion regulation and its effects on negative affect and smoking cessation|
|Title:||Evaluating Concomitant Use of Very Low Nicotine Content Cigarettes and E-cigarettes Among Daily and Non-Daily Smokers on Abuse Liability|
|Title:||Gender differences in Standard Research E-Cigarette (SREC) product use, acceptability, reinforcement, and nicotine dependence symptoms|